Countries facing steep import tariffs are also likely to sue the U.S. for compensation, experts say.
Gun control advocates may see this as war of attrition, but businesses cutting ties with the NRA might not be doing so to take a moral stand—it’s just good business.
“If an ad tries to scare people into getting a new vaccine...those who are thinking about God won’t respond as strongly.”
President Donald Trump has failed to make golf great again in his hometown.
Disney is about to control a major stake in the world of streaming entertainment. And it's bad news for other streaming services.
The blurring of lines between online retailers and their brick-and-mortar counterparts are positioning two of America's largest retailers against each other.
Wu, who has stepped aside as chairman of Anbang Insurance, could be the highest-profile target in a recent campaign against corruption by Chinese investigators.
Trump now has at least 123 registered or approved trademarks across China.
Nigeria’s trade minister says the country could be a springboard for U.S. businesses in Africa, predicting good relations under President Trump.
Over-the-air transmission of audio and pictures is headed for extinction, because in a fully wired world, there is no need for it.
The United States has given its approval to China's One Belt One Road project.
Even if we took away the iPhone, Apple still has a diverse portfolio that is larger than Google and Microsoft.
The emoluments clause has never been litigated; so whether Trump’s foreign business dealings violate it is a matter of interpretation with no previous precedent.
Under Armour has since released a statement saying Plank's comments were in regard to Trump's business policies, not his social viewpoints.
Doubts deepened over the weekend as Trump declared he would replace President Barack Obama's signature healthcare plan known as Obamacare with "insurance for everybody."
President Xi Jinping made a vigorous defence of globalization at the World Economic Forum.
Trump campaigned on an "America First" anti-globalization platform that promised the return of thousands of U.S. manufacturing jobs to economically depressed areas.
Takeda CFO James Kehoe said the company was on the hunt for hit drugs.